VAERS Table of Reportable Events Following Vaccination

VAERS Table of Reportable Events Following Vaccination

https://vaers.hhs.gov/index

VAERS Table of Reportable Events Following Vaccination*

 

Vaccine/Toxoid Event and interval from vaccination

 

Tetanus in any combination; DTaP, DTP, DTP-Hib,

DT, Td, TT, Tdap, DTaP-IPV, DTaP-IPV/Hib, DTaPHepB-

IPV

A. Anaphylaxis or anaphylactic shock (7 days)

B. Brachial neuritis (28 days)

C. Any acute complications or sequelae (including death)

of above events (interval – not applicable)

D. Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

Pertussis in any combination; DTaP, DTP, DTPHib,

Tdap, P, DTaP-IPV, DTaP-IPV/Hib, DTaPHepB-

IPV

A. Anaphylaxis or anaphylactic shock (7 days)

B. Encephalopathy or encephalitis (7 days)

C. Any acute complications or sequelae (including death)

of above events (interval – not applicable)

D.

 

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

Measles, mumps and rubella in any combination;

MMR, MR, M, MMRV, R

A. Anaphylaxis or anaphylactic shock (7 days)

B. Encephalopathy or encephalitis (15 days)

C. Any acute complications or sequelae (including death)

of above events (interval – not applicable)

D. Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

Rubella in any combination; MMR, MMRV, MR, R

A. Chronic arthritis (42 days)

B. Any acute complications or sequelae (including death)

of above event (interval – not applicable)

C. Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

Measles in any combination; MMR, MMRV, MR, M

A. Thrombocytopenic purpura (7-30 days)

B. Vaccine-strain measles viral infection in an

immunodeficient recipient (6 months)

C. Any acute complications or sequelae (including death)

of above events (interval – not applicable)

D. Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

Oral Polio (OPV)

A. Paralytic polio

o

 

in a non-immunodeficient recipient (30 days)

o

 

in an immunodeficient recipient (6 months)

o

 

in a vaccine-associated community case

(interval – not applicable)

B. Vaccine-strain polio viral infection

o

 

in a non-immunodeficient recipient (30 days)

o

 

in an immunodeficient recipient (6 months)

 

VAERS Table of Reportable Events Following Vaccination*

 

Vaccine/Toxoid Event and interval from vaccination

 

o

 

in a vaccine-associated community case

(interval – not applicable)

C. Any acute complication or sequelae (including death) of

above events (interval – not applicable)

D. Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

Inactivated Polio -IPV, DTaP-IPV, DTaP-IPV/HIB,

DTaP-HepB-IPV

A. Anaphylaxis or anaphylactic shock (7 days)

B. Any acute complication or sequelae (including death) of

the above event (interval – not applicable)

C. Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

Hepatitis B in any combination- HepB, HepAHepB,

DTaP-HepB-IPV, Hib-HepB

A. Anaphylaxis or anaphylactic shock (7 days)

B. Any acute complications or sequelae (including death)

of the above event (interval – not applicable)

C. Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval

– see package insert)

 

Hemophilus influenzae

 

type b in any combination

(conjugate)- Hib, Hib-HepB, DTP-Hib, DTaPIPV/

Hib

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

Varicella in any combination- VAR, MMRV

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

Rotavirus (monovalent or pentavalent) RV1, RV5

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

Pneumococcal conjugate (7-valent or 13-valent)

PCV7, PCV13

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

Hepatitis A in any combination- HepA, HepA-HepB

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

Influenza–t

 

rivalent inactivated influenza , live

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

 

VAERS Table of Reportable Events Following Vaccination*

 

Vaccine/Toxoid Event and interval from vaccination

 

attenuated influenza

 

TIV, LAIV

Meningococcal – MCV4, MPSV4

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

Human Papillomavirus (Quadrivalent or Bivalent)-

HPV4, HPV2

Events described in manufacturer’s package insert as

contraindications to additional doses of vaccine (interval – see

package insert)

* Effective date: November 10, 2008

 

 

. The Reportable Events Table (RET) reflects what is reportable by law (42 USC

300aa-25) to the Vaccine Adverse Event Reporting System (VAERS) including conditions found in the manufacturers

package insert. In addition, healthcare professionals are encouraged to report any clinically significant or unexpected

events (even if you are not certain the vaccine caused the event) for any vaccine, whether or not it is listed on the RET.

Manufacturers are also required by regulation (21CFR 600.80) to report to the VAERS program all adverse events made

known to them for any vaccine.

A list of vaccine abbreviations is attached and is also located at:

 

http://www.cdc.gov/vaccines/recs/acip/vac

 

 

 

 

 

abbrev.htm

 

Vaccine Abbreviation

 

 

 

*

Diphtheria and tetanus toxoids adsorbed (children) DT

Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed DTaP

Diphtheria and tetanus toxoids and whole cell pertussis vaccine DTP

Diphtheria and tetanus toxoids and whole cell pertussis vaccine and

 

Haemophilus influenzae type

b conjugate vaccine

DTP-Hib

Tetanus and diphtheria toxoids adsorbed (adult) Td

Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed Tdap

Tetanus toxoid TT

Diphtheria and tetanus toxoids and acellular pertussis adsorbed and

 

Haemophilus influenzae type

b conjugate vaccine

DTaP/Hib

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B and inactivated

poliovirus vaccine

DTaP-HepBIPV

Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine DTaP-IPV

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and

 

Haemophilus influenzae

 

type b conjugate vaccine

DTaP-IPV/Hib

 

Haemophilus influenzae

 

type b conjugate vaccine Hib

 

Haemophilus influenzae

 

type b conjugate and hepatitis B vaccine Hib-HepB

Hepatitis A vaccine

HepA

Hepatitis B vaccine

HepB

Hepatitis A inactivated and hepatitis B vaccine

HepA-HepB

Human papillomavirus vaccine (quadrivalent)

HPV4

Human papillomavirus vaccine (bivalent)

HPV2

Trivalent inactivated influenza vaccine

TIV

Live attenuated influenza vaccine

LAIV

Measles vaccine

M

Measles and rubella vaccine

MR

Measles, mumps, and rubella vaccine MMR

Measles, mumps, rubella, and varicella vaccine

MMRV

Meningococcal conjugate vaccine (quadrivalent)

MCV4

Meningococcal polysaccharide vaccine (quadrivalent)

MPSV4

Pertussis

P

Pneumococcal conjugate vaccine (7-valent)

PCV7

Pneumococcal conjugate vaccine (13-valent)

PCV13

Poliovirus vaccine (inactivated)

IPV

Poliovirus vaccine (live)

OPV

Rubella vaccine

R

Rotavirus vaccine (monovalent)

RV1

Rotavirus vaccine (pentavalent)

RV5

Varicella vaccine

VAR

*dash (-) indicates: products that are supplied in their final form by the manufacturer and do not require

mixing or reconstitution by user; slash ( / ) indicates: products that are mixed or reconstituted by user.